Awan Health Ltd 08971076 false 2023-03-31 2024-03-29 2024-03-29 The principal activity of the company is the provision of healthcare services. Digita Accounts Production Advanced 6.30.9574.0 true true 08971076 2023-03-31 2024-03-29 08971076 2024-03-29 08971076 bus:OrdinaryShareClass1 2024-03-29 08971076 2 2024-03-29 08971076 core:CurrentFinancialInstruments 2024-03-29 08971076 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-29 08971076 core:FurnitureFittingsToolsEquipment 2024-03-29 08971076 1 2024-03-29 08971076 bus:SmallEntities 2023-03-31 2024-03-29 08971076 bus:AuditExemptWithAccountantsReport 2023-03-31 2024-03-29 08971076 bus:FilletedAccounts 2023-03-31 2024-03-29 08971076 bus:SmallCompaniesRegimeForAccounts 2023-03-31 2024-03-29 08971076 bus:RegisteredOffice 2023-03-31 2024-03-29 08971076 bus:Director1 2023-03-31 2024-03-29 08971076 bus:OrdinaryShareClass1 2023-03-31 2024-03-29 08971076 bus:PrivateLimitedCompanyLtd 2023-03-31 2024-03-29 08971076 core:OfficeEquipment 2023-03-31 2024-03-29 08971076 countries:EnglandWales 2023-03-31 2024-03-29 08971076 1 2023-03-31 2024-03-29 08971076 2023-03-30 08971076 core:FurnitureFittingsToolsEquipment 2023-03-30 08971076 1 2023-03-30 08971076 2022-04-01 2023-03-30 08971076 2023-03-30 08971076 bus:OrdinaryShareClass1 2023-03-30 08971076 2 2023-03-30 08971076 core:CurrentFinancialInstruments 2023-03-30 08971076 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-30 08971076 core:FurnitureFittingsToolsEquipment 2023-03-30 08971076 1 2023-03-30 08971076 1 2022-04-01 2023-03-30 08971076 1 2022-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 08971076

Awan Health Ltd

Unaudited Filleted Financial Statements

for the Period from 31 March 2023 to 29 March 2024

 

Awan Health Ltd

Contents

Balance Sheet

1

Notes to the Financial Statements

2 to 5

 

Awan Health Ltd

(Registration number: 08971076)
Balance Sheet as at 29 March 2024

Note

2024
£

2023
£

Current assets

 

Debtors

5

27,893

95,863

Cash at bank and in hand

 

7,000

7,876

 

34,893

103,739

Creditors: Amounts falling due within one year

6

(750)

(5,884)

Net assets

 

34,143

97,855

Capital and reserves

 

Called up share capital

8

100

100

Retained earnings

34,043

97,755

Shareholders' funds

 

34,143

97,855

For the financial period ending 29 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 28 January 2025
 

.........................................
Dr T S A Awan
Director

 

Awan Health Ltd

Notes to the Financial Statements for the Period from 31 March 2023 to 29 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
15 Merchants Quay
Blackburn
Lancashire
BB1 1BS

These financial statements were authorised for issue by the director on 28 January 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Awan Health Ltd

Notes to the Financial Statements for the Period from 31 March 2023 to 29 March 2024

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

25% per annum reducing balance basis

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

 

Awan Health Ltd

Notes to the Financial Statements for the Period from 31 March 2023 to 29 March 2024

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 2 (2023 - 2).

4

Tangible assets

Office equipment
 £

Total
£

Cost

At 31 March 2023

200

200

At 29 March 2024

200

200

Depreciation

At 31 March 2023

200

200

At 29 March 2024

200

200

Net book value

At 29 March 2024

-

-

At 30 March 2023

-

-

 

Awan Health Ltd

Notes to the Financial Statements for the Period from 31 March 2023 to 29 March 2024

5

Debtors

Note

2024
£

2023
£

Other debtors

 

27,492

95,863

Corporation tax recoverable

401

-

 

27,893

95,863

6

Creditors

2024
£

2023
£

Due within one year

Taxation and social security

-

5,134

Accruals and deferred income

750

750

750

5,884

7

Related party transactions

Transactions with the director

2024

At 31 March 2023
£

Advances to director
£

Repayments by director
£

At 29 March 2024
£

Loans to director

95,863

27,492

(95,863)

27,492

 

2023

At 1 April 2022
£

Advances to director
£

Repayments by director
£

At 30 March 2023
£

Loans to director

124,774

95,863

(124,774)

95,863

 

Interest charged on the above loan at 2.25% (2023 - 2%).

8

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100